Last reviewed: July 12, 2026
Last updated: July 12, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Tirzepatide is a dual GLP-1 and GIP receptor agonist that produces sustained weight loss when dosed correctly for your body. Finding your optimal dose requires understanding how the medication works, what clinical trials show, and how your personal health factors influence your response. PlexusDx helps patients navigate this journey with expert guidance and affordable compounded tirzepatide injections.
Start your GLP-1 program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.
Start your intake →
How Tirzepatide Dosing Works: Starting Low and Titrating Up
Tirzepatide dosing follows a step-wise titration schedule designed to minimize side effects while building to your therapeutic dose. Most patients start at 2.5 mg weekly, then increase by 2.5 mg every four weeks until reaching their maintenance level between 5 mg and 15 mg per week. This gradual approach allows your body to adapt to the medication while your prescribing clinician monitors your weight loss progress and tolerability.
The initial four-week period at a lower dose serves an important purpose: it helps your digestive system acclimate to how tirzepatide reduces appetite and slows stomach emptying. Patients who rush titration or start at higher doses often experience more nausea, vomiting, and constipation. Clinical data shows that slower titration schedules correlate with better long-term adherence and sustained weight loss outcomes.
Understanding Maintenance Doses: Which Tier Is Right for You
Maintenance doses for tirzepatide typically range from 5 mg to 15 mg administered once weekly via injection. Many patients achieve meaningful weight loss at 5 mg or 10 mg, while some benefit from the maximum approved dose of 15 mg. Your optimal maintenance dose depends on your baseline weight, metabolic health, concurrent medications, and how your body responds during the titration phase.
Research from the SURMOUNT clinical trials found that patients at the 15 mg dose lost approximately 20-22% of their baseline body weight over 72 weeks, while 10 mg doses produced 18-20% reductions. However, individual responses vary significantly, and some patients achieve their weight loss goals at lower doses with fewer side effects. PlexusDx recommends working with your prescribing clinician to find the lowest effective dose rather than automatically jumping to higher levels.
Genetic Factors That Influence Your Tirzepatide Response
Your genetics play a measurable role in how well tirzepatide works for your weight loss and metabolism. Variants in genes like GLP1R rs6923761, GIPR rs1800437, and MC4R rs17782313 influence how strongly your body responds to the medication and how efficiently your system processes hunger and satiety signals. Individuals with certain genetic patterns may require different doses or experience different side effect profiles than others taking the same medication.
PlexusDx offers the Precision Peptide Genetic Test, which analyzes 14 metabolic pathways and 150+ genetic insights related to GLP-1 responsiveness and peptide biology. This test, available for $99 as an add-on after your first month of treatment, helps your clinician understand your unique genetic predispositions and may inform whether a lower or higher maintenance dose could be more effective for your body. Genetic testing removes guesswork from dose selection and personalizes your weight loss plan.
Managing Side Effects While Titrating Your Dose
Nausea, constipation, and decreased appetite are common during tirzepatide titration and often diminish as your body adjusts. Staying hydrated, eating small frequent meals, and incorporating fiber gradually into your diet can significantly reduce gastrointestinal discomfort. If side effects become severe at any dose level, your clinician may extend the titration window or recommend a slower increase before advancing to the next tier.
Some patients naturally plateau at doses lower than 15 mg because they achieve their weight loss goals with fewer side effects at that level. This is a positive outcome, not a treatment failure. PlexusDx emphasizes that your dose may need to go up, but your price won't—compounded tirzepatide injections remain at $289/mo (or $249/mo on the 6-month plan) regardless of which dose level you're taking, making it financially safe to stay at your optimal dose without pressure to escalate.
Comparing Tirzepatide to Other GLP-1 Options for Dosing
Tirzepatide differs from semaglutide in its dual-receptor mechanism and dosing structure. While semaglutide typically reaches maintenance doses of 2.4 mg weekly, tirzepatide's higher therapeutic range of 5-15 mg weekly reflects its additional GIP receptor activity. Some patients achieve better weight loss with tirzepatide's dual action, while others respond equally well to semaglutide at a lower price point. PlexusDx compounded semaglutide is $189 per month month-to-month, or from $149/mo on the 6-month plan, offering a more affordable entry point for patients exploring GLP-1 therapy.
Patients uncertain whether tirzepatide or semaglutide suits their needs can work with PlexusDx clinicians to evaluate their individual factors and goals. PlexusDx also offers GLP-Squared Injection, a dual-compound combining semaglutide and tirzepatide, starting at $289 per month for patients seeking the synergistic benefits of both agents. Your prescribing clinician will guide you toward the option with the best risk-benefit profile for your metabolic health and weight loss objectives.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the typical starting dose of tirzepatide for weight loss?
Most patients begin tirzepatide at 2.5 mg injected once weekly, then increase by 2.5 mg every four weeks until reaching their maintenance dose. This gradual titration reduces nausea and allows your body to adapt while your clinician monitors your progress. PlexusDx helps personalize this schedule based on your response and tolerability.
How long does it take to reach my maintenance dose on tirzepatide?
Standard titration takes 12-16 weeks to progress from 2.5 mg to a full maintenance dose of 10-15 mg. Some patients extend each step longer if they experience side effects, while others titrate faster if they tolerate the medication well. Your PlexusDx clinician will customize your timeline to balance efficacy and comfort.
Will my PlexusDx price increase if I increase my tirzepatide dose?
No. PlexusDx compounded tirzepatide injections are priced at $289/mo (or $249/mo on the 6-month plan) flat across all dose levels, with no per-dose or dose-ladder pricing. Your dose may need to go up; your price won't. This structure removes financial barriers to finding your optimal therapeutic dose.
Can genetic testing help determine my ideal tirzepatide dose?
Yes. The PlexusDx Precision Peptide Genetic Test analyzes variants in GLP1R, GIPR, MC4R, and FTO genes that influence how your body responds to tirzepatide. Available for $99 after your first treatment month, this test reveals your genetic predispositions for peptide responsiveness and helps your clinician select your optimal dose more accurately.
What if tirzepatide side effects persist during titration?
Persistent nausea, vomiting, or constipation may require extending your titration timeline or adjusting your maintenance dose downward. Many patients find adequate weight loss at 5-10 mg with significantly fewer side effects than 15 mg. Your PlexusDx clinician will work with you to balance effectiveness and tolerability.
Is compounded tirzepatide as effective as brand-name Mounjaro?
Yes. PlexusDx sources tirzepatide from licensed 503A compounding pharmacies that meet strict quality and purity standards. Compounded tirzepatide contains identical active pharmaceutical ingredients and achieves the same clinical outcomes as brand-name Mounjaro at a fraction of the cost.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How Much Weight Loss Can You Expect on Mounjaro 5mg?
Where Are You Supposed to Inject Mounjaro?